Sax Wealth Advisors’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.9K Sell
20,050
-138
-0.7% -$176 ﹤0.01% 537
2026
Q1
$25.4K Sell
20,188
-110
-0.5% -$135 ﹤0.01% 482
2025
Q4
$25.6K Sell
20,298
-82
-0.4% -$114 ﹤0.01% 489
2025
Q3
$31.6K Buy
20,380
+220
+1% +$302 ﹤0.01% 437
2025
Q2
$26.6K Buy
20,160
+50
+0.2% +$68 ﹤0.01% 422
2025
Q1
$33.4K Hold
20,110
– – ﹤0.01% 360
2024
Q4
$29.6K Hold
20,110
– – ﹤0.01% 328
2024
Q3
$30K Hold
20,110
– – ﹤0.01% 287
2024
Q2
$25.1K Hold
20,110
– – ﹤0.01% 274
2024
Q1
$24.1K Hold
20,110
– – ﹤0.01% 190
2023
Q4
$30.4K Buy
20,110
+110
+0.6% +$159 0.01% 189
2023
Q3
$32K Hold
20,000
– – 0.01% 178
2023
Q2
$43.4K Hold
20,000
– – 0.01% 176
2023
Q1
$29.2K Hold
20,000
– – 0.01% 176
2022
Q4
$25K Buy
+20,000
New +$31.5K 0.01% 169
2022
Q1
– Sell
-84,110
Closed -$405K – 184
2021
Q4
$405K Sell
84,110
-25,491
-23% -$103K 0.08% 126
2021
Q3
$400K Buy
+109,601
New +$408K 0.09% 112

Other funds holding OPK

Sax Wealth Advisors's OPK Position: Q2 2026 in Review

Sax Wealth Advisors reduced its Opko Health (OPK) stake by 0.68% in Q2 2026, selling an estimated $176 and leaving 20,050 shares worth $22.9K. The position accounts for ﹤0.01% of the portfolio, ranked #537.

Sax Wealth Advisors first reported a position in OPK in Q3 2021 and has held it in 17 quarters since. The position peaked at $405K in Q4 2021. 222 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

  • Sax Wealth Advisors held 20,050 shares of Opko Health worth $22.9K as of Q2 2026.
  • Sax Wealth Advisors sold 138 Opko Health shares in Q2 2026, an estimated $176.
  • Opko Health made up ﹤0.01% of Sax Wealth Advisors's portfolio in Q2 2026, its #537 holding.
  • Sax Wealth Advisors first reported a position in Opko Health in Q3 2021 and has held it in 17 quarters since.
  • Sax Wealth Advisors's Opko Health position peaked at $405K in Q4 2021.
  • 222 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on Sax Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.